Results 141 to 150 of about 104,865 (311)
Long-term management reporting credibility data from an accounting experiment. [PDF]
Gooden E, Holden N.
europepmc +1 more source
Optimal portfolios of a long-term investor with floor or drawdown constraints [PDF]
Vladimir Cherny, Jan Obłój
openalex +1 more source
This review examines emerging combination immunotherapy strategies tailored to distinct tumor microenvironments and highlights next‐generation biomarkers that guide response prediction and treatment personalization. It integrates lessons from unsuccessful trials, addresses toxicity challenges, and outlines approaches for early biomarker discovery and ...
Asmita Pandey +6 more
wiley +1 more source
SSE forecasts based on market-sentiment dual anchoring. [PDF]
Yang L, Gan B, Niu X, Liu Q.
europepmc +1 more source
This study develops a 3D co‐culture and co‐differentiation system for porcine muscle stem cells (pMuSCs) and mesenchymal stem cells (pMSCs) on edible starch‐based scaffolds. The system simultaneously generates myotubes and adipocytes without using serum or chemical inducers.
Xin Guan +9 more
wiley +1 more source
Tissue and organ engineering: Investor sentiments and analysis. [PDF]
Velcani F +6 more
europepmc +1 more source
This study is pioneering in constructing the shortest known synthetic pathway for L‐theanine production from xylose within E coli. Through comprehensive metabolic engineering strategies, our engineered strain achieved the highest reported L‐theanine titer from xylose, with a titer of 95.42 g/L, and a yield of 0.55 g/g.
Haolin Han +5 more
wiley +1 more source
StockData: An open investment transaction dataset. [PDF]
Li M, Wu C, Mao W, Firat EE, Laramee RS.
europepmc +1 more source
Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy
Cancer immunotherapy faces challenges in predicting treatment responses and understanding resistance mechanisms. Artificial intelligence (AI) and machine learning (ML) offer powerful solutions for cancer immunotherapy in patient stratification, biomarker discovery, treatment strategy optimization, and foundation model development.
Xinchao Wu +4 more
wiley +1 more source

